> top > docs > PMC:3359311 > spans > 16508-16725 > annotations

PMC:3359311 / 16508-16725 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T5634 45-50 P01584 denotes IL-1β

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Speculation
T5489 38-44 Regulation denotes alters true
T5490 45-50 Protein denotes IL-1β
T5491 51-61 Gene_expression denotes production
R4748 T5490 T5491 themeOf IL-1β,production
R4749 T5491 T5489 themeOf production,alters

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T5829 21-25 Protein denotes CFTR
T5830 45-50 Protein denotes IL-1β
T5831 145-149 Protein denotes CFTR
T5832 26-37 Positive_regulation denotes dysfunction
T5833 51-61 Gene_expression denotes production
T5834 38-44 Positive_regulation denotes alters
R5046 T5829 T5832 themeOf CFTR,dysfunction
R5047 T5830 T5833 themeOf IL-1β,production
R5048 T5832 T5834 causeOf dysfunction,alters
R5049 T5833 T5834 themeOf production,alters

events-check-again

Id Subject Object Predicate Lexical cue Speculation
T5815 38-44 Regulation denotes alters true
T5816 45-50 Protein denotes IL-1β
T5817 51-61 Gene_expression denotes production
R5037 T5816 T5817 themeOf IL-1β,production
R5038 T5817 T5815 themeOf production,alters

GO-CC

Id Subject Object Predicate Lexical cue
T5787 69-74 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T5674 0-2 TO denotes To
T5675 3-12 VB denotes determine
T5676 13-20 IN denotes whether
T5677 21-25 NNP denotes CFTR
T5678 26-37 NN denotes dysfunction
T5679 38-44 VBZ denotes alters
T5680 45-50 JJ denotes IL-1β
T5681 51-61 NN denotes production
T5682 61-62 , denotes ,
T5683 63-68 CD denotes THP-1
T5684 69-74 NNS denotes cells
T5685 75-78 CC denotes and
T5686 79-84 NNS denotes PBMCs
T5687 85-89 IN denotes from
T5688 90-92 NNP denotes CF
T5689 93-101 NNS denotes patients
T5690 102-105 CC denotes and
T5691 106-113 JJ denotes healthy
T5692 114-122 NNS denotes controls
T5693 123-127 VBD denotes were
T5694 128-135 VBN denotes treated
T5695 136-140 IN denotes with
T5696 141-144 DT denotes the
T5697 145-149 NNP denotes CFTR
T5698 150-159 NN denotes inhibitor
T5699 159-160 , denotes ,
T5700 161-171 NNP denotes CFTRinh172
T5701 171-172 , denotes ,
T5702 173-178 RB denotes prior
T5703 179-181 TO denotes to
T5704 182-192 NN denotes simulation
T5705 193-197 IN denotes with
T5706 198-202 JJ denotes live
T5707 203-205 NNP denotes P.
T5708 206-216 NN denotes aeruginosa
T5709 216-217 . denotes .
R4919 T5674 T5675 aux To,determine
R4920 T5675 T5694 advcl determine,treated
R4921 T5676 T5679 mark whether,alters
R4922 T5677 T5678 amod CFTR,dysfunction
R4923 T5678 T5679 nsubj dysfunction,alters
R4924 T5679 T5675 ccomp alters,determine
R4925 T5680 T5681 amod IL-1β,production
R4926 T5681 T5694 nsubjpass production,treated
R4927 T5682 T5681 punct ",",production
R4928 T5683 T5684 nummod THP-1,cells
R4929 T5684 T5681 conj cells,production
R4930 T5685 T5684 cc and,cells
R4931 T5686 T5684 conj PBMCs,cells
R4932 T5687 T5681 prep from,production
R4933 T5688 T5689 compound CF,patients
R4934 T5689 T5687 pobj patients,from
R4935 T5690 T5689 cc and,patients
R4936 T5691 T5692 amod healthy,controls
R4937 T5692 T5689 conj controls,patients
R4938 T5693 T5694 auxpass were,treated
R4939 T5694 T5694 ROOT treated,treated
R4940 T5695 T5694 prep with,treated
R4941 T5696 T5698 det the,inhibitor
R4942 T5697 T5698 compound CFTR,inhibitor
R4943 T5698 T5695 pobj inhibitor,with
R4944 T5699 T5698 punct ",",inhibitor
R4945 T5700 T5698 appos CFTRinh172,inhibitor
R4946 T5701 T5698 punct ",",inhibitor
R4947 T5702 T5694 advmod prior,treated
R4948 T5703 T5702 prep to,prior
R4949 T5704 T5703 pobj simulation,to
R4950 T5705 T5694 prep with,treated
R4951 T5706 T5708 amod live,aeruginosa
R4952 T5707 T5708 compound P.,aeruginosa
R4953 T5708 T5705 pobj aeruginosa,with
R4954 T5709 T5694 punct .,treated

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T5537 0-2 TO denotes To
T5538 3-12 VB denotes determine
T5539 13-20 IN denotes whether
T5540 21-25 NN denotes CFTR
T5541 26-37 NN denotes dysfunction
T5542 38-44 VB denotes alters
T5543 45-50 NN denotes IL-1β
T5544 51-61 NN denotes production
T5545 61-62 -COMMA- denotes ,
T5546 63-68 NN denotes THP-1
T5547 69-74 NN denotes cells
T5548 75-78 CC denotes and
T5549 79-84 NN denotes PBMCs
T5550 85-89 IN denotes from
T5551 90-92 NN denotes CF
T5552 93-101 NN denotes patients
T5553 102-105 CC denotes and
T5554 106-113 JJ denotes healthy
T5555 114-122 NN denotes controls
T5556 123-127 VB denotes were
T5557 128-135 VB denotes treated
T5558 136-140 IN denotes with
T5559 141-144 DT denotes the
T5560 145-149 NN denotes CFTR
T5561 150-159 NN denotes inhibitor
T5562 159-160 -COMMA- denotes ,
T5563 161-171 NN denotes CFTRinh172
T5564 171-172 -COMMA- denotes ,
T5565 173-178 JJ denotes prior
T5566 179-181 TO denotes to
T5567 182-192 NN denotes simulation
T5568 193-197 IN denotes with
T5569 198-202 JJ denotes live
T5570 203-205 NNP denotes P.
T5571 206-216 NN denotes aeruginosa
R4787 T5538 T5537 arg1Of determine,To
R4788 T5541 T5540 arg1Of dysfunction,CFTR
R4789 T5541 T5542 arg1Of dysfunction,alters
R4790 T5542 T5538 arg2Of alters,determine
R4791 T5542 T5539 arg1Of alters,whether
R4792 T5544 T5542 arg2Of production,alters
R4793 T5544 T5543 arg1Of production,IL-1β
R4794 T5547 T5546 arg1Of cells,THP-1
R4795 T5547 T5548 arg1Of cells,and
R4796 T5548 T5556 arg1Of and,were
R4797 T5548 T5557 arg2Of and,treated
R4798 T5549 T5548 arg2Of PBMCs,and
R4799 T5549 T5550 arg1Of PBMCs,from
R4800 T5552 T5551 arg1Of patients,CF
R4801 T5552 T5553 arg1Of patients,and
R4802 T5553 T5550 arg2Of and,from
R4803 T5555 T5553 arg2Of controls,and
R4804 T5555 T5554 arg1Of controls,healthy
R4805 T5557 T5537 modOf treated,To
R4806 T5557 T5545 arg1Of treated,","
R4807 T5557 T5556 arg2Of treated,were
R4808 T5557 T5558 arg1Of treated,with
R4809 T5561 T5558 arg2Of inhibitor,with
R4810 T5561 T5559 arg1Of inhibitor,the
R4811 T5561 T5560 arg1Of inhibitor,CFTR
R4812 T5561 T5562 arg1Of inhibitor,","
R4813 T5563 T5562 arg2Of CFTRinh172,","
R4814 T5563 T5564 arg1Of CFTRinh172,","
R4815 T5563 T5565 arg1Of CFTRinh172,prior
R4816 T5565 T5566 arg1Of prior,to
R4817 T5567 T5566 arg2Of simulation,to
R4818 T5567 T5568 arg1Of simulation,with
R4819 T5571 T5568 arg2Of aeruginosa,with
R4820 T5571 T5569 arg1Of aeruginosa,live
R4821 T5571 T5570 arg1Of aeruginosa,P.

sentences

Id Subject Object Predicate Lexical cue
T5499 0-217 Sentence denotes To determine whether CFTR dysfunction alters IL-1β production, THP-1 cells and PBMCs from CF patients and healthy controls were treated with the CFTR inhibitor, CFTRinh172, prior to simulation with live P. aeruginosa.
T115 0-217 Sentence denotes To determine whether CFTR dysfunction alters IL-1β production, THP-1 cells and PBMCs from CF patients and healthy controls were treated with the CFTR inhibitor, CFTRinh172, prior to simulation with live P. aeruginosa.